| 000 | 01313nam a2200325 a 4500 | ||
|---|---|---|---|
| 005 | 20250914142609.0 | ||
| 008 | 820526s1982 nyua b 101 0 eng | ||
| 020 | _a0444007245 | ||
| 039 | 9 |
_a200603031724 _bzaina _c200602151208 _dmanaf _y02-15-2006 _zmanaf |
|
| 090 | _aRS431.A64M438 1981 | ||
| 090 |
_aRS431.A64 _bM438 1981 |
||
| 111 | 2 |
_aMedicinal Chemistry Symposium _n(22nd : _d1981 : _cAmherst, N.Y.) |
|
| 245 | 1 | 0 |
_aNew approaches to the design of antineoplastic agents : _bproceedings of the Twenty-second Annual Medicinal Chemistry Symposium, Amherst, New York, U.S.A., May 18-20, 1981 / _ceditors, Thomas J. Bardos and Thomas I. Kalman |
| 260 |
_aNew York : _bElsevier Biomedical, _c1982 |
||
| 300 |
_axxiii, 337 p. : _bill. ; _c24 cm. |
||
| 504 | _aIncludes references and indexes | ||
| 650 | 0 |
_aAntineoplastic agents _xCongresses |
|
| 650 | 0 |
_aPharmaceutical chemistry _xCongresses |
|
| 650 | 0 |
_aEnzyme inhibitors _xCongresses |
|
| 650 | 0 |
_aChemical mutagenesis _xCongresses |
|
| 700 | 1 | _aBardos, Thomas J. | |
| 700 | 1 | _aKalman, Thomas I. | |
| 907 |
_a.b13675539 _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kRS431.A64M438 1981 |
||
| 914 | _avtls003321524 | ||
| 990 | _azsz | ||
| 991 | _aFakulti Sains Teknologi | ||
| 998 |
_at _b2006-02-02 _cm _da _feng _gnyu _y0 _z.b13675539 |
||
| 999 |
_c366205 _d366205 |
||